- Info
- Portfolio
- Significant Ownership
- Insider Ownership
- Insider Trading
- Financials
- Holders
Significant Ownership of Merck & Co., Inc.
- Signature - Title
- /s/ Kelly Grez - Kelly Grez/Corporate Secretary
- Location
- Rahway, NJ
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Merck & Co., Inc..
Follow Filing Activity
Follow Merck & Co., Inc. and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Merck & Co., Inc.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| EVAX | Evaxion Biotech A/S | American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share | 20% | $105,531,938 | 63,004,142 | Merck & Co., Inc. | 31 Jan 2025 | ||
| PSNL | Personalis, Inc. | Common Stock, $0.0001 par value per share | 16% | $53,792,132 | 14,044,943 | Merck & Co., Inc. | 19 Dec 2024 |
Schedules 13D/G Reported by Merck & Co., Inc.:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.